Columbia University: Lymphoma trials

The registry lists 10 Lymphoma studies with Columbia University as lead sponsor. 0 are open to participants now and 7 have results posted.

Phase 1 4Phase 2 8No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Study of Copanlisib and Ketogenic DietTerminatedNCT04750941Phase 2Results posted
• TGR1202 in Relapsed and Refractory Follicular LymphomaTerminatedNCT03178201Phase 2Results posted
• Carfilzomib and TGR-1202 in Treatment of R/R LymphomaTerminatedNCT02867618Phase 1/2Results posted
• Romidepsin Plus Oral 5-Azacitidine in Relapsed/Refractory Lymphoid MalignanciesTerminatedNCT01998035Phase 1/2Results posted
• Lenalidomide in HTLV-1 Adult T-Cell LeukemiaCompletedNCT01274533Phase 2Results posted
• Autologous and Allogeneic Transplant for Relapsed LymphomaCompletedNCT00802113Phase 1/2Results posted
• Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid TumorsCompletedNCT00365768Phase 2Results posted
• Copanlisib in Combination With Romidepsin in Patients With Relapsed or Refractory Mature T-cell LymphomaWithdrawnNCT04233697Phase 1
• Denileukine Diftitox for Relapsed ALCLWithdrawnNCT00801918Phase 2
• Blood Stem Cell Transplant in Treating Patients With Hematologic CancerTerminatedNCT00008216